Clinical Trial Update: PLATELET RICH FIBRIN COMBINED WITH 1.2% ATORVASTATIN FOR TREATMENT OF INTRABONY DEFECTS IN CHRONIC PERIODONTITIS [Phase 2]

View source ↗

Summary

Phase 2 trial investigating platelet-rich fibrin combined with 1.2% atorvastatin for intrabony defects in chronic periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Platelet Rich Fibrin (platelet-rich fibrin)
• atorvastatin (1.2%) (atorvastatin)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Periodontitis | Phase 2 | Status: COMPLETED